Cite
Zometa in therapy for bone metastases of prostate cancer during androgenic deprivation (Results of Russian multicenter study)
MLA
O. B. Karyakin, et al. “Zometa in Therapy for Bone Metastases of Prostate Cancer during Androgenic Deprivation (Results of Russian Multicenter Study).” Onkourologiâ, vol. 3, no. 2, Mar. 2020, pp. 56–60. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doajarticles..01ba45ce85bfb453e009b339b09c7223&authtype=sso&custid=ns315887.
APA
O. B. Karyakin, B. P. Matveev, V. B. Matveev, I. G. Rusakov, O. B. Loran, Ye. I. Veliyev, L. V. Shaplygin, B. V. Bukharkin, V. A. Biryukov, N. G. Minayeva, A. A. Atayev, V. M. Shelepova, M. I. Karelin, D. G. Prokhorov, Yu. N. Khrizman, V. K. Shakurov, E. F. Abdrakhmanov, V. N. Zhuravlev, A. V. Zyryanov, … P. A. Karnaukh. (2020). Zometa in therapy for bone metastases of prostate cancer during androgenic deprivation (Results of Russian multicenter study). Onkourologiâ, 3(2), 56–60.
Chicago
O. B. Karyakin, B. P. Matveev, V. B. Matveev, I. G. Rusakov, O. B. Loran, Ye. I. Veliyev, L. V. Shaplygin, et al. 2020. “Zometa in Therapy for Bone Metastases of Prostate Cancer during Androgenic Deprivation (Results of Russian Multicenter Study).” Onkourologiâ 3 (2): 56–60. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doajarticles..01ba45ce85bfb453e009b339b09c7223&authtype=sso&custid=ns315887.